This fact sheet outlines PATH's pneumococcal vaccine project from a technical perspective. It includes an overview of PATH's vaccine development portfolio and partners to support the development of vaccines against pneumonia and other pneumococcal diseases that can be effective and affordable for children in the developing world.

Publication date: April 2018

Region: Global

This publication describes PATH’s efforts to examine the use and acceptability of maternal influenza immunization in El Salvador. The qualitative study captures the perspectives of pregnant women, family decision makers, community leaders, public health practitioners, private physicians, and more. The report identifies both successful strategies as well as challenges to vaccine uptake, and offers recommendations for countries considering the introduction of maternal influenza immunization.

Publication date: April 2018

Region: Latin America, Global

This document provides an overview of the global, multisectoral Coalition for Access to NCD Medicines & Products. The coalition is dedicated to increasing access to essential medicines and health products to reduce the impact of noncommunicable diseases (NCDs) such as diabetes and cardiovascular disease.

Publication date: March 2018

Region: Africa, Global

PATH is collaborating with the Novartis Foundation to introduce an innovative healthcare delivery model designed to improve hypertension management and control in Vietnam. The project aims to improve blood pressure control among adults by increasing access to and use of high-quality hypertension services that are sustainable and scalable.

Publication date: March 2018

Region: Asia, Global

From 2014 to 2016, PATH coordinated pilot introduction of the injectable contraceptive subcutaneous DMPA (DMPA-SC, brand name Sayana® Press) in Burkina Faso, Niger, Senegal, and Uganda. These materials feature guidance for monitoring DMPA-SC introductions, monitoring results, and lessons learned, which can help inform contraceptive introduction programming for DMPA-SC and other methods. For more information, please visit our subcutaneous DMPA (Sayana Press) introduction and research page.

Publication date: March 2018

Region: Africa, Global

In Vietnam, the USAID/PATH Healthy Markets project is collaborating with MTV Vietnam to empower young people to prevent and manage HIV. Healthy Markets and MTV Vietnam have now reached more than 1.5 million people with information about new services and products, like community-based HIV testing and pre-exposure prophylaxis, and is encouraging open conversations about HIV, safe sex, and being LGBT+ in Vietnam.

Publication date: March 2018

Region: Asia, Global

Blow-fill-seal (BFS) technologies use a polymer material to form the container. BFS is widely used for packaging of single-dose pharmaceuticals, but has yet to be introduced for vaccines. The BFS manufacturing process can accommodate the filling of multiple containers into a single strip with a flexible detachment point, allowing for the easy separation of each unit-dose container at the point of delivery.

Publication date: February 2018

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH's work on designing the next generation of jet injectors.

Publication date: February 2018

Region: Global

Part of series: Technology Updates

This Vaccine and Pharmaceutical Technologies documents answers frequently asked questions regarding one type of freeze-preventive vaccine carrier. It includes why vaccine freezing is a problem, the benefits of freeze-preventive carriers, and the next steps for the technology.

Publication date: February 2018

Region: Global

Part of the Technology Updates series, this fact sheet describes PATH’s work on freeze-preventive vaccine carriers to address the problem of vaccines freezing during transport.

Publication date: February 2018

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH's work on an intradermal adapter, which makes it easier to administer intradermal injections.

Publication date: February 2018

Region: Global

Part of series: Technology Updates

PATH and its partners are in the early stages of developing microarray patches (MAPs) containing cabotegravir for HIV pre-exposure prophylaxis (PrEP), as well as a MAP containing cabotegravir and a contraceptive—a multipurpose protection technology (MPT).

Publication date: February 2018

Region: Global

PATH’s global community of donors and partners stepped up to support health equity through the Reach Campaign, our first major fundraising initiative. This report shares the final campaign results, including what PATH donors have made possible through their support.

Publication date: February 2018

Region: Global

Part of series: Reports to contributors

Part of the Technology Updates series, this fact sheet describes PATH's work on technologies to make the reconstitution of critical vaccines simpler, safer, and more economical. Streamlined reconstitution processes also help reduce medical wastage.

Publication date: February 2018

Region: Global

Part of series: Technology Updates

Advocacy is an effective method to achieve global health goals by ensuring that necessary resources, policies, and political will are available to support important programs. These resources help new and experienced advocates assess policy advocacy options, plan goals and activities, and develop a comprehensive strategy for advocacy impact. For more information, please visit: http://sites.path.org/advocacyandpolicy/how-we-do-it/strengthen-advocacy-capacity/.

Publication date: February 2018

Region: Africa, Asia, Global

This publication captures the milestones and process used by PATH in its role as Market Manager for the introduction and scale of 7.1% chlorhexidine for umbilical cord care globally over the last ten years.

Publication date: January 2018

Region: Global

This document was created to support ministry of health and nongovernmental partners as they develop strategies to introduce and scale up subcutaneous DMPA (DMPA-SC, brand name Sayana® Press) to increase contraceptive options and access. Available in English and French, the publication provides practical guidance based on results, evidence, and learning from the pilot introductions of Sayana Press in four countries in Africa. For more information, visit PATH's Reproductive Health Global Program website.

Publication date: January 2018

Region: Global

Subcutaneous DMPA (DMPA-SC, Sayana® Press) is a new, easy-to-use injectable contraceptive that is ideally suited for remote access and even self-injection. This brief provides an overview of PATH’s research studies assessing the feasibility and acceptability of self-injection in Uganda and Senegal. For more information, please visit our Reproductive Health Global Program website.

Publication date: January 2018

Region: Global

Part of series: Sayana Press (DMPA-SC in Uniject) introduction and research fact sheets

Subcutaneous DMPA is an innovative injectable contraceptive that can dramatically expand access and choice for women. A new initiative led by PATH and John Snow Inc., the Subcutaneous DMPA Access Collaborative is working with ministries of health and partners across sectors to strengthen scale-up and build toward a robust global market for the product. For more information, visit http://sites.path.org/rh/?p=292.

Publication date: January 2018

Region: Global

This case study examines the use of advocacy for increased misoprostol access in Nigeria, specifically the market-based approach taken by PATH and the Generation Initiative for Women and Youth network to design an initiative for increasing public-sector use of the drug.

Publication date: December 2017

Region: Africa, Global